BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 18627789)

  • 1. Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-kappaB activation- and EGFR transactivation-dependent mechanisms.
    Lin CI; Chen CN; Huang MT; Lee SJ; Lin CH; Chang CC; Lee H
    Cell Signal; 2008 Oct; 20(10):1804-14. PubMed ID: 18627789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic acid up-regulates vascular endothelial growth factor-C and lymphatic marker expressions in human endothelial cells.
    Lin CI; Chen CN; Huang MT; Lee SJ; Lin CH; Chang CC; Lee H
    Cell Mol Life Sci; 2008 Sep; 65(17):2740-51. PubMed ID: 18642114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid mediates interleukin-8 expression in human endometrial stromal cells through its receptor and nuclear factor-kappaB-dependent pathway: a possible role in angiogenesis of endometrium and placenta.
    Chen SU; Lee H; Chang DY; Chou CH; Chang CY; Chao KH; Lin CW; Yang YS
    Endocrinology; 2008 Nov; 149(11):5888-96. PubMed ID: 18617617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic acid up-regulates expression of interleukin-8 and -6 in granulosa-lutein cells through its receptors and nuclear factor-kappaB dependent pathways: implications for angiogenesis of corpus luteum and ovarian hyperstimulation syndrome.
    Chen SU; Chou CH; Lee H; Ho CH; Lin CW; Yang YS
    J Clin Endocrinol Metab; 2008 Mar; 93(3):935-43. PubMed ID: 18171700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid-induced transactivation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E(2) release via C/EBPbeta in human bronchial epithelial cells.
    He D; Natarajan V; Stern R; Gorshkova IA; Solway J; Spannhake EW; Zhao Y
    Biochem J; 2008 May; 412(1):153-62. PubMed ID: 18294142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells.
    Mu H; Calderone TL; Davies MA; Prieto VG; Wang H; Mills GB; Bar-Eli M; Gershenwald JE
    Am J Pathol; 2012 May; 180(5):2170-81. PubMed ID: 22465753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic acid enhances vascular endothelial growth factor-C expression in human prostate cancer PC-3 cells.
    Lin CE; Chen SU; Lin CC; Chang CH; Lin YC; Tai YL; Shen TL; Lee H
    PLoS One; 2012; 7(7):e41096. PubMed ID: 22911748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LPA
    Lin YC; Chen CC; Chen WM; Lu KY; Shen TL; Jou YC; Shen CH; Ohbayashi N; Kanaho Y; Huang YL; Lee H
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1305-1315. PubMed ID: 30053596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expression.
    Chuang YW; Chang WM; Chen KH; Hong CZ; Chang PJ; Hsu HC
    PLoS One; 2014; 9(5):e95180. PubMed ID: 24879414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic acid up-regulates expression of growth-regulated oncogene-alpha, interleukin-8, and monocyte chemoattractant protein-1 in human first-trimester trophoblasts: possible roles in angiogenesis and immune regulation.
    Chen SU; Chou CH; Chao KH; Lee H; Lin CW; Lu HF; Yang YS
    Endocrinology; 2010 Jan; 151(1):369-79. PubMed ID: 19906815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Glucose Induces VEGF-C Expression via the LPA1/3-Akt-ROS-LEDGF Signaling Axis in Human Prostate Cancer PC-3 Cells.
    Huang YL; Lin YC; Lin CC; Chen WM; Chen BPC; Lee H
    Cell Physiol Biochem; 2018; 50(2):597-611. PubMed ID: 30317243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional and post-transcriptional mechanisms for lysophosphatidic acid-induced cyclooxygenase-2 expression in ovarian cancer cells.
    Oyesanya RA; Lee ZP; Wu J; Chen J; Song Y; Mukherjee A; Dent P; Kordula T; Zhou H; Fang X
    FASEB J; 2008 Aug; 22(8):2639-51. PubMed ID: 18362203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer.
    Bhattacharjee RN; Timoshenko AV; Cai J; Lala PK
    Cancer Sci; 2010 Sep; 101(9):2026-32. PubMed ID: 20608938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.
    Flister MJ; Wilber A; Hall KL; Iwata C; Miyazono K; Nisato RE; Pepper MS; Zawieja DC; Ran S
    Blood; 2010 Jan; 115(2):418-29. PubMed ID: 19901262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysophosphatidic acid regulates inflammation-related genes in human endothelial cells through LPA1 and LPA3.
    Lin CI; Chen CN; Lin PW; Chang KJ; Hsieh FJ; Lee H
    Biochem Biophys Res Commun; 2007 Nov; 363(4):1001-8. PubMed ID: 17923111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between prostaglandin E2 and vascular endothelial growth factor (VEGF) in angiogenesis in human vascular endothelial cells.
    Tamura K; Sakurai T; Kogo H
    Vascul Pharmacol; 2006 Jun; 44(6):411-6. PubMed ID: 16651031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autotaxin signaling via lysophosphatidic acid receptors contributes to vascular endothelial growth factor-induced endothelial cell migration.
    Ptaszynska MM; Pendrak ML; Stracke ML; Roberts DD
    Mol Cancer Res; 2010 Mar; 8(3):309-21. PubMed ID: 20197381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells.
    Symowicz J; Adley BP; Woo MM; Auersperg N; Hudson LG; Stack MS
    Cancer Res; 2005 Mar; 65(6):2234-42. PubMed ID: 15781636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative regulation of cell motile and invasive activities by lysophosphatidic acid receptor-3 in colon cancer HCT116 cells.
    Fukui R; Tanabe E; Kitayoshi M; Yoshikawa K; Fukushima N; Tsujiuchi T
    Tumour Biol; 2012 Dec; 33(6):1899-905. PubMed ID: 22763559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid does not cause blood/lymphatic vessel plasticity in the rat mesentery culture model.
    Sweat RS; Azimi MS; Suarez-Martinez AD; Katakam P; Murfee WL
    Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27401461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.